Adma Biologics ADMA
NASDAQ ADMA
$9.72 -0.21 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Depreciation and Depletion (2018 - 2020)

Updated

Adma Biologics (ADMA) recorded Depreciation and Depletion of $900,000 in Q3 2020, up 50.0% from $600,000 a year earlier and up 28.6% from the prior quarter.

Analysis

Adma Biologics (ADMA) Depreciation and Depletion (2018 - 2020) Analysis & Trends

On a TTM basis, Adma Biologics' Depreciation and Depletion came in at $2.8 million as of Sep 30, 2020, up 16.7% year-over-year.

  • The Q3 2020 figure is the highest quarterly Depreciation and Depletion in data going back to Q1 2018.
  • On a year-over-year basis, Depreciation and Depletion rose in two of the last six quarters, with growth averaging 11.1%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Adma Biologics 2.24 Bn 1.81 Bn 86.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 900,000.00
Jun 30, 2020 700,000.00
Mar 31, 2020 600,000.00
Sep 30, 2019 600,000.00
Jun 30, 2019 600,000.00
Mar 31, 2019 600,000.00
Sep 30, 2018 600,000.00
Jun 30, 2018 600,000.00
Mar 31, 2018 600,000.00
API Access

Adma Biologics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ADMA&period=max&api_key=YOUR_API_KEY